Latest News

Sedana Medical (OM:SEDANA) continues to operate at a loss, with net losses deepening at a steady rate of 1% per year over the last five years and ongoing forecasts pointing to unprofitability for at least the next three years. Meanwhile, revenue is expected to grow an impressive 26.45% per year, well outpacing the Swedish market average of 3.9% each year. This makes strong sales growth the central reward for investors weighing the company’s persistent challenges in reaching profitability. See...

Thinking about whether to buy, hold, or sell Mercury Systems? You are definitely not alone right now. The stock has been making headlines, and not just for its one-year climb of 137.6%. In just the past week, Mercury’s shares have jumped 5.1%, adding to a strong 6.9% gain over the past month and a stunning 87.7% run year-to-date. That kind of trajectory tends to split opinions. Is it the start of a new chapter or just a high point in a volatile story? Recent interest has been fueled by talks...

Carpenter Technology (CRS) reported annual revenue growth forecasts of 6.6%, which trails the broader US market’s expected 10% pace. EPS is projected to grow at 13.2%, slightly below the market average of 15.5%. In the latest figures, the company delivered 82.1% year-over-year earnings growth and has seen profit margins climb to 14.3% from just 8% a year prior. These accelerating profitability results come with share price trading above estimated fair value, setting the stage for debate about...

With a price-to-earnings (or "P/E") ratio of 7.7x CDA S.A. ( WSE:CDA ) may be sending bullish signals at the moment...

If you’re debating what to do with NGEx Minerals, you’re not alone. The stock has been impossible to ignore, especially for anyone paying attention to high-growth stories in the resource sector. NGEx Minerals closed recently at $25.86 and, for those tracking the numbers, is up 2.4% over the past week and 5.0% for the last month. Those are nice gains, but it’s the outsized longer-term surge that really catches the eye: a 95.5% return so far this year, 117.9% over the past twelve months, and an...

There wouldn't be many who think Byggma ASA's ( OB:BMA ) price-to-sales (or "P/S") ratio of 0.4x is worth a mention...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Avidia Bancorp (AVBC) remains unprofitable, with losses accelerating at an average annual rate of 43.1% over the past five years. Net profit margin has shown no improvement in the last year, and there have been no reports of profitability during this period. See our full analysis for Avidia Bancorp. The real test is how these numbers stack up against the prevailing market narratives. Some views will get reinforced, while others may be challenged. Curious how numbers become stories that shape...

Associated Banc-Corp (ASB) is set for an earnings comeback, with forecasts pointing to 33.2% annual EPS growth and 14.9% annual revenue growth over the next three years. This is notably ahead of the US market’s 10% revenue pace. Despite this upbeat outlook, the company’s earnings have actually declined by 16% per year over the past five years, and profit margins have narrowed to 14.9% from 18% a year ago. While investors may be drawn to the attractive dividend and improving growth narrative,...

United Bancshares (UBOH) posted a notable turnaround in its latest results, with earnings growing 40.8% over the past year, a dramatic improvement compared to its five-year average decline of 10.3% per year. Net profit margins climbed to 25.8%, up from 21.1% a year ago, showing a stronger operational performance. The combination of currently high-quality earnings and a Price-To-Earnings ratio of 8.7x, well below industry and peer averages, sets a value-oriented backdrop for investors...

EastGroup Properties (EGP) capped another year of steady growth, with revenue expanding at 9.7% per year, which is slightly below the broader US market’s pace. The company’s EPS is forecast to climb 10.3% annually, also trailing the US average, while profit margins compressed, dipping from last year’s 37% to 35.7%. Despite the modest slowdown, a five-year earning growth rate of 14.3% underscores EastGroup’s longer-term consistency, even as the most recent annual gain moderated to 6.8%. See...

Thinking about what to do with Recursion Pharmaceuticals stock? You are not alone. The last few months have given shareholders a rollercoaster to ride, marked by bursts of optimism and hints of concern. In just the past week, the stock nudged up 3.1%, but step back a little further and the swings get much sharper. Recursion is up an impressive 23.8% in the last month. However, peel back the curtain on the longer-term picture and the story cools: year-to-date, shares are still down by 16.2%,...

With a median price-to-earnings (or "P/E") ratio of close to 15x in Greece, you could be forgiven for feeling...

Thinking about what to do with Element Solutions stock? You are not alone. In a market packed with shifting trends and endless options, this company has quietly caught attention again, both for its long-term results and intriguing valuation numbers. Over just the past week, Element Solutions ticked up 2.3%, adding to a modest 3.3% gain for the last 30 days. Year to date, it is up 4.0%. Taking a step back, the picture gets more interesting: while returns dipped slightly over the past year, the...

MORI TRUST REIT (TSE:8961) expects revenue to decline by 0.4% per year and earnings to fall by 3% per year over the next three years. Net profit margins have narrowed to 57.3% from 64.4% in the previous year. Over the past five years, however, earnings have grown by 9.5% annually, highlighting a period of growth that now appears to be waning as profit margins contract. See our full analysis for MORI TRUST REIT. Next, we will set these latest results against the prevailing narratives for MORI...

Helix Energy Solutions Group (HLX) delivered standout earnings momentum this year, with its net profit margin rising to 3.2% from just 0.5% a year ago. EPS growth has surged an impressive 493.9% over the past year, while the company’s earnings have maintained a brisk 29.7% average annual increase over the last five years. Investors are eyeing projected profit growth of 46.8% per year for the next three years, far above the US market average. At the same time, revenue is expected to grow at a...

Thinking about what’s next for Amundi’s stock? You are not alone. Whether you have held on through the years or are weighing a new position, it is hard to ignore a company that has delivered nearly 71% growth over the past three years. Even if the pace has slowed, with a 3.0% rise so far this year and a modest 1.0% bump just this past week, there is a sense that something is stirring beneath the surface. Some of that recent uplift comes on the back of Amundi’s push into new markets and the...

Sanofi (ENXTPA:SAN) delivered net profit margins of 14%, up from 9.3% a year ago, and last year’s earnings grew 73.6% after five years of average annual declines of 14.5%. With earnings now forecast to climb 12.48% per year and profit and revenue expected to outpace the broader French market, these headline numbers make a strong case for a shift in investor sentiment. Improved profitability, a six-reward indicator profile, and a substantially lower Price-To-Earnings Ratio compared to peers...

Southside Bancshares (SBSI) reported a net profit margin of 33.6%, dipping slightly from 34.1% a year earlier, while earnings growth over the last year came in at 4.5% after years of averaging a 3.5% annual decline. Looking forward, analysts project the company's earnings will grow at 3.99% per year with revenue expected to rise 5.6% annually, both trailing the broader US market's averages. Despite these modest growth forecasts, the stock is trading at a discounted 9.7x Price-To-Earnings...

Ready Capital (RC) shares dropped nearly 30% after the company reported quarterly results that did not meet expectations. This decline came as slower growth in net interest income and falling earnings per share have raised new questions about its long-term profitability. See our latest analysis for Ready Capital. After a steep 30% share price drop over the last month, Ready Capital's recent losses have only compounded a tough year. Its year-to-date share price return stands at -54.8%, with a...

Booz Allen Hamilton (BAH) posted net profit margins of 8.7%, a jump from last year’s 5.5%, while earnings showed a striking 71.1% year-over-year increase, much higher than the company’s 5-year average annual growth of 11.4%. With a current Price-To-Earnings Ratio of 10.9x, shares trade at a deep discount to peers and well below the US Professional Services industry average, underscoring their value credentials. Investors have reason to appreciate strong profit momentum and margin expansion,...

Illinois Tool Works (ITW) reported annual earnings growth of 9.1% over the past five years, with most recent earnings rising 9.7% and a net profit margin expanding to 21.3% from 19.2% a year earlier. The stock trades at $245.75, which is below an estimated fair value of $582.03 and comes with a price-to-earnings ratio of 21.3x, a discount to both the US Machinery industry and its peer group. With a strong past earnings record, attractive dividend, and improved margins, the latest results give...

Provident Bancorp (PVBC) reported a net profit margin of 20.2%, more than doubling from 9.6% the previous year and highlighting a significant improvement in profitability. Earnings growth for the past twelve months came in at 136.1%, far surpassing the company’s five-year average, though longer-term earnings have actually declined by an average of 8.2% per year. Looking ahead, consensus calls for earnings to decrease 3.8% annually over the next three years and for revenue to grow just 1.7%...